Surgical Innovations (GB:SUN)
LSE:SUN
UK Market

Surgical Innovations (SUN) Financial Statements

5 Followers

Surgical Innovations Financial Overview

Surgical Innovations's market cap is currently ―. The company's EPS TTM is p0; its P/E ratio is -14.64; Surgical Innovations is scheduled to report earnings on September 17, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 2.20M£ 3.04M£ 3.64M£ 4.69M£ 5.28M
Total Assets£ 15.60M£ 15.81M£ 15.72M£ 16.07M£ 16.34M
Total Debt£ 2.16M£ 2.38M£ 2.79M£ 3.02M£ 3.27M
Net Debt£ -38.00K£ -658.00K£ -857.00K£ -1.67M£ -2.01M
Total Liabilities£ 4.63M£ 5.13M£ 5.05M£ 5.06M£ 5.25M
Stockholders Equity£ 10.96M£ 10.67M£ 10.66M£ 11.01M£ 11.09M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Surgical Innovations Earnings and Revenue History

Surgical Innovations Debt to Assets

Surgical Innovations Cash Flow

Surgical Innovations Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis